Modulation of classical neurotransmitter systems by σ receptors

Sigma Receptors: Chemistry, Cell Biology and Clinical Implications

Volumn , Issue , 2007, Pages 195-214

  Werling, Linda L ^a   Derbez, Alicia E ^a   Nuwayhid, Samer J ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951047087     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-36514-5_10     Document Type: Chapter

References (83)

1. Aydar E, Palmer CP, Klyachko VA, Jackson MB. The σ receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 2002, 34:399-410.
2. + channel modulation in rodent neurohypophysial nerve terminals by σ receptors and not by dopamine receptors. J Physiol 1999a, 517:391-406.
3. Wilke RA, Mehta RP, Luparadus PJ, Chen Y, Ruoho AE, Jackson MB. Sigma receptor photolabeling and σ receptor-mediated modulation of potassium channels in tumor cells. J Biol Chem 1999b, 18387-18392.
4. 1 receptors. Proc Natl Acad Sci USA 2001, 98:491-496.
5. 1 receptors. Trends Pharmacol Sci 2001, 22:456-8.
6. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 1995, 92:3774-3778.
7. 1 receptors may not be directly coupled to G proteins. Eur J Pharmacol 2000, 408:117-125.
8. Boyer JL, Graber SG, Waldo GL, Harden K, Garrison JC. Selective activation of phospholipase C by recombinant G-protein α- And β/-subunits. J Biol Chem 1994. 269:2814-2819.
9. 2 receptor subtypes. Neuroscience 1997, 76:467-477.
10. 1/σ2 binding in rat brain. Eur J Pharmacol 1994, 259:65-69.
11. 1 receptor in the adult rat central nervous system. Neuroscience 2000, 97:155-170.
12. 1 (sigma-1) receptor in the mammalian brain and its possible relevance in definits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 2000, 20:375-387.
13. 2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. Synapse 1994, 17:182-189.
14. 1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA 1999, 96:8196-8199.
15. 2+ concentration. J Pharmacol Exp Ther 2000, 293:788-798.
16. Bowen WD. sigma receptors: recent advances and new clinical potentials. Pharmaceutica Acta Helvetica 2000, 74:211 -218.
17. 3H]dopamine release from rat striatal slices by a receptor ligands. J Pharm Exp Ther 1994, 271:212-219.
18. 2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol Exp Ther 2000, 292:900-911.
19. Bergeron R, Debonnel G, DeMontigny C. Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands. Eur J Pharmacol 1993; 240:319-323.
20. Bergeron R, deMontigny C, Debonnel G. Biphasic effects of σ ligands on the neuronal response to N-methyl-D-aspartate. Naunyn-Schmeid Arch Pharmacol 1995, 351:252-260.
21. 3 region of the rat dorsal hippocampus. Br J Pharmacol 1997, 120:1351-1359.
22. Bergeron R, deMontigny C, Debonnel G. Pregnancy reduces brain σ receptor function. Br J Pharmacol 1999, 127:1769-1776.
23. Monnet FP, Debonnel G, Junien JL, DeMontigny C. N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur J Pharmacol 1990, 79:441-445.
24. Debonnel G, Bergeron R, deMontigny C. Potentiation by dehydroepiandosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: An effect mediated via σ receptors. J Endocrinol 1996, 150 Suppl:S33- S42.
25. Monnet FP, Debonnel G, Bergeron R, Gronier B, deMontingny C. The effects of σ ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurons are differentially affected by pertussis toxin. Br J Pharmacol 1994, 112:709-715.
26. Klette KL, Lin Y, Clapp LE, DeCoster MA, Moreton JE, Tortella FC. Neuroprotective a ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 1997, 756:231-240.
27. Shimazu S, Katsuki H, Takenada C, Tomita M, Kuma T, Kaneko S, Akaike A. Sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures. Eur J Pharmacol 2000, 388:139-146.
28. Vilner BJ, deCosta BR, Bowen WD. Cytotoxic effects of σ ligands: σ receptor-mediated alterations in cellular morphology and viability. J Neurosci 1995, 15:643-654.
29. 3H]-3-[3-hydroxyphenyl]-N-(l-propyl)piperidine and [3H]-1-[1-(2- Thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 1986, 238:739-748.
30. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Ann Rev Pharmacol Toxicol 1989, 29:365-402.
31. Guitart X, Mendez R, Ovalle S, Andreu F, Carceller A, Farre AJ, Zamanillo D. Regulation of ionotropic glutamate receptor subunits in different rat brain areas by σ preferential σ, receptor ligand and potential antipsychotic. Neuropsychopharmacology 2000, 23:539-546.
32. Annels SJ, Ellis Y, Davies JA. Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices. Brain Res 1991, 15:341-343.
33. Ellis Y, Davies JA. The effects of σ ligands on the release of glutamate from rat striatal slices. Naunyn-Schmeidebergs Arch Pharmacol 1994, 350:143-148.
34. Matsuno K, Matsunaga K, Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazoxine as measured by brain microdialysis. Brain Res 1992, 575:315-219.
35. Matsuno K, Matsunaga K, Senda T, Mita S. Increase in extracellular acetylcholine level by σ ligands in rat frontal cortex. J Pharm Exp Ther 1993, 26:851-859.
36. Kobayashi T, Matsuno K, Mita S. Regional differences of the effect of σreceptor ligands on the acetylcholine release in the rat brain. J Neural Transm Gen Sect 1996a, 103:661-669.
37. Kobayashi T, Matsuno K, Nakata K, Mita S. Enhancement of acetylcholine release by SA4503, a novel σ, receptor agonist, in the rat brain. J Pharm Exp Ther 1996b, 279:106-113.
38. Junien JL, Roman FJ, Brunells G, Pascaud X. J01784, a novel σ, ligand, potentiates [3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 1991, 200:343-345.
39. 3H-acetylcholine from striatal and hippocampal rat brain slices. Synapse 2002, 46:1-3.
40. Matsuno K, Senda T, Matsunaga K, Mita S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: Involvement in the central acetylcholinergic system. Eur J Pharmacol 1994, 11:43-51.
41. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996, 315:1-10.
42. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J Pharm Exp Ther 1976, 197:517-532.
43. Vaupel DB. Naltrexone fails to antagonize the σ effects of PCP and SKF 10, 047 in the dog. Eur J Pharmacol 1983, 92:264-269.
44. 3H](+)SKF-10, 047- binding protein partially purified from rat liver and rat brain membranes: An opioid/σ receptor? Synapse 1997, 25:117-124.
45. Couture S, Debonnel G. Some of the effects of the selective σ ligand (+)pentazocine are mediated via a naloxone-sensitive receptor. Synapse 2001, 39:323-331.
46. Chien C-C, Pasternak GW. Selective antagonism of opioid analgesia by a σ system. J Pharm Exp Ther 1994, 271:1583-1590.
47. Chien C-C, Pasternak GW. (-)-Pentazocine analgesia in mice: Interactions with a σ receptor system. J Pharm Exp Ther 1995a, 271:1583-1590.
48. Chien C-C, Pasternak GW. σ Antagonists potentiate opioid analgesia in rats. Neuroscience Lett 1995b, 190:137-139.
49. Rossi G, Leventhal L, Bolan EA, Pasternak GW. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharm Exp Ther 1997, 282:858-865.
50. Rossi G, Leventhal L, Pasternak GW. Naloxone-sensitive orphanin/FQ-induced analgesia in mice Eur J Pharmacol 1996, 311:R7-R8.
51. + channel in Xenopus oocytes. Br J Pharmacol 1997, 120:986-987.
52. King MA, Bradshaw S, Chang AH, Pintar JE, Pasternak GW. Potentiation of opioid analgesia in dopamine-2 receptor knock-out mice: evidence for a tonically active anti- opioid system. J Neurosci 2001, 21:7788-7792.
53. Gudelsky GA. Effects of ct receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. Eur J Pharmacol 1995, 286:223-228.
54. 1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons. Eur J Pharmacol 1999, 378:31-37.
55. Booth RG, Baldessarini RJ. (+)-6, 7-benzomorphan σ ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res 1991, 557:349-352.
56. Gronier B, Debonnel G. Involvement of σ receptors in the modulation of glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur J Pharmacol 1999, 368(2-3): 183-196.
57. 3H]dopamine release via a presynaptic mechanism. Eur J Pharmacol 1995b, 294:713-719.
58. 1, receptors. Naunyn-Schmeideberg Arch Pharmacol 1997; 356:455-461.
59. 1receptors. Schizophrenia Res 1996, 21:51 -62.
60. Nuwayhid SJ, Werling LL. Sigma-1 receptor agonist-mediated regulation of N-methyl- D-aspartate-stimulated [3H]dopamine release is dependent upon PKC. J Pharm Exp Ther 2002, 364-369.
61. Sanchez C, Nuwayhid SJ, Werling LL. Signaling of NPY receptors and ct receptors via and PLC/PKC system. (In preparation) 2005.
62. Novakova M, Ela C, Bowen WD, Hasin Y, Elim Y. Highly selective σ receptor ligands elevate inositol 1, 4, 5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol. 1998, 353:315-327.
63. Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 2000, 80:1291-1335.
64. Werling LL. Sigma receptor-active steroids and neurotransmitter release. Int J Neuropsychopharmacology 2002, 5:S292.
65. Roman FJ, Pascaud X, Duffy O, Vauche D, Martin B, Junien JL. Neuropeptide Y and peptide YY interact with rat brain or and PCP binding sites. Eur J Pharmacol 1989, 174:301-302.
66. 1-like receptor. J Pharm Exp Ther 1998, 284:553-560.
67. 3H]dopamine release from rat striatum by neuropeptide Y and σ receptor ligands. Brain Res 1997, 760:210-217.
68. 1 receptor antagonists. Schizophrenia Res 1998, 31:27-36.
69. Hong W, Werling LL. Lack of effects by σ ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum. Brain Res 2001, 901:208-218.
70. Parker SL, Parker MS, Swaetman T, Cowley WR. Characterization of the G protein and phospholipase C-coupled agonist binding to the Y-l neuropeptide Y receptor in rat brain: Sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. J Pharm Exp Ther 1998, 286:382-391.
71. Gudelsky GA. Biphasic effect of σ receptor ligands on the extracellular concentration of dopamine in the striatum of rat. J Neural Transm 1999, 106:849-856.
72. 2 receptor agonists and antagonists in vitro. Eur J Pharmacol 1998, 346: 189-196.
73. 3H]dopamine release from rat pheochromocytoma (PC 12) cells by σ2 receptors. J Pharm Exp Ther 1999, 289:278-284.
74. Derbez AE, Werling LL. Sigma-2 receptor regulation of dopamine transporter activity via protein kinase C. J Pharmacol Exp Ther 2002, 301:306-314.
75. 3H]dopamine release in vitro. Eur J Pharmacol 2001, 422:39-45.
76. 1 and σ 2 binding sites in rat and guinea pig brain membranes: novel subtype- selective trishomocubanes. Eur J Pharmacol 1996, 311:233-240.
77. --dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 2001, 92(1): 21-55.
78. Gonzalez-Alvear GM, Werling LL. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res 1995a, 673:61-69.
79. Gonzalez-Alvear GM, Thompson-Montgomery D, Deben SE, Werling LL. Functional and binding properties of o receptors in rat cerebellum. J Neurochem 1995, 65: 2509-2516.
80. 2 receptors. Eur J Pharmacol 1997, 326:133-138.
81. 3H]noradrenaline release in rat hippocampal slices. Br J Pharmacol 1996, 119:65-72.
82. Hong W, Nuwayhid SJ, Werling LL. Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism. Synapse 2004 54:102-110.
83. 2) receptors as a target for cocaine action in the rat striatum. Eur J Pharmacol 2006 535:98-103.